YY1-induced PART1 directly binds to the miR-512-3p target and regulates the CHRAC1 (Chromatin Accessibility Complex Subunit 1), thereby increasing the cisplatin resistance of ovarian cancer.[49] Cervical cancer is a common gynecological tumor and is closely related to high risk subtypes of human papillomavirus (HPV).[50] High-risk-HPV infection is an important factor causing cervical cancer in women. This evidence concerns the gene CHRAC1 and ovarian carcinoma.